Style | Citing Format |
---|---|
MLA | Iraji F, et al.. "The Safety of Diclofenac for the Management and Treatment of Actinic Keratoses." Expert Opinion on Drug Safety, vol. 7, no. 2, 2008, pp. 167-172. |
APA | Iraji F, Siadat AH, Asilian A, Enshaieh S, Shahmoradi Z (2008). The Safety of Diclofenac for the Management and Treatment of Actinic Keratoses. Expert Opinion on Drug Safety, 7(2), 167-172. |
Chicago | Iraji F, Siadat AH, Asilian A, Enshaieh S, Shahmoradi Z. "The Safety of Diclofenac for the Management and Treatment of Actinic Keratoses." Expert Opinion on Drug Safety 7, no. 2 (2008): 167-172. |
Harvard | Iraji F et al. (2008) 'The Safety of Diclofenac for the Management and Treatment of Actinic Keratoses', Expert Opinion on Drug Safety, 7(2), pp. 167-172. |
Vancouver | Iraji F, Siadat AH, Asilian A, Enshaieh S, Shahmoradi Z. The Safety of Diclofenac for the Management and Treatment of Actinic Keratoses. Expert Opinion on Drug Safety. 2008;7(2):167-172. |
BibTex | @article{ author = {Iraji F and Siadat AH and Asilian A and Enshaieh S and Shahmoradi Z}, title = {The Safety of Diclofenac for the Management and Treatment of Actinic Keratoses}, journal = {Expert Opinion on Drug Safety}, volume = {7}, number = {2}, pages = {167-172}, year = {2008} } |
RIS | TY - JOUR AU - Iraji F AU - Siadat AH AU - Asilian A AU - Enshaieh S AU - Shahmoradi Z TI - The Safety of Diclofenac for the Management and Treatment of Actinic Keratoses JO - Expert Opinion on Drug Safety VL - 7 IS - 2 SP - 167 EP - 172 PY - 2008 ER - |